TipRanks
Go Ultimate75% OFF

Thomas Okarma Insider Profile

4 Followers

Thomas Okarma, President & CEO at Geron, holds 1.70K shares in Asterias Biotherapeutics (Ticker: AST), holds 774.56K shares in Geron (Ticker: GERN).

Thomas Okarma's Trading History

AST
Asterias Biotherapeutics
Sep 27, 2013―Uninformative Buy―$1.61K
GERN
Geron
Jul 13, 2010President & CEOUninformative Buy―$766.04K

You May Also Like

Thomas Okarma insider profile FAQ

What is the percentage of profitable transactions made by Thomas Okarma?
The percentage of profitable transactions made by Thomas Okarma is 80%.
What is the average return per transaction made by Thomas Okarma?
The average return per transaction made by Thomas Okarma is 9.20%.
What stocks does Thomas Okarma hold?
Thomas Okarma holds: GERN, AST stocks.
What was Thomas Okarma's most profitable transaction?
Thomas Okarma’s most profitable transaction was an Informative Sell of GERN stock on June 3, 2010. The return on the trade was 26.10%.
What is Thomas Okarma's role in Geron?
Thomas Okarma's role in Geron is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.